MIRA Pharmaceuticals, Inc.

Developing the next generation of oral ketamine and pharmaceutical marijuana analogs to treat neurologic neuropsychiatric disorders

Improved Therapies with Potential Results

With small changes, MIRA's technology focuses on big effects that have the potential to redefine therapeutic outcomes, opening up new markets for indications and patients.

Learn About MIRA-55

Learn About Ketamir